J Ma, W Chen, Z Hu, J Huang, C Guo,
C Zou… - Investigational New …, 2022 - Springer
Pertuzumab is a recombinant anti-HER2 humanized monoclonal antibody widely used for
the adjuvant treatment of HER2-positive breast cancer. Its safety is well established with the …